×
S&P 500   3,774.97 (-0.28%)
DOW   30,695.57 (-0.26%)
QQQ   278.94 (-0.48%)
AAPL   136.97 (+0.18%)
MSFT   256.57 (-0.10%)
META   157.00 (-2.64%)
GOOGL   2,150.08 (-1.34%)
AMZN   107.99 (+1.68%)
TSLA   673.21 (-0.03%)
NVDA   146.24 (-3.53%)
NIO   21.12 (-2.76%)
BABA   115.18 (+1.32%)
AMD   73.61 (-3.74%)
MU   52.58 (-4.88%)
CGC   2.85 (+0.35%)
T   21.05 (+0.43%)
GE   63.03 (-1.01%)
F   11.22 (+0.81%)
DIS   95.10 (+0.74%)
AMC   13.51 (-0.30%)
PFE   51.75 (-1.30%)
PYPL   70.31 (+0.67%)
NFLX   176.67 (+1.03%)
S&P 500   3,774.97 (-0.28%)
DOW   30,695.57 (-0.26%)
QQQ   278.94 (-0.48%)
AAPL   136.97 (+0.18%)
MSFT   256.57 (-0.10%)
META   157.00 (-2.64%)
GOOGL   2,150.08 (-1.34%)
AMZN   107.99 (+1.68%)
TSLA   673.21 (-0.03%)
NVDA   146.24 (-3.53%)
NIO   21.12 (-2.76%)
BABA   115.18 (+1.32%)
AMD   73.61 (-3.74%)
MU   52.58 (-4.88%)
CGC   2.85 (+0.35%)
T   21.05 (+0.43%)
GE   63.03 (-1.01%)
F   11.22 (+0.81%)
DIS   95.10 (+0.74%)
AMC   13.51 (-0.30%)
PFE   51.75 (-1.30%)
PYPL   70.31 (+0.67%)
NFLX   176.67 (+1.03%)
S&P 500   3,774.97 (-0.28%)
DOW   30,695.57 (-0.26%)
QQQ   278.94 (-0.48%)
AAPL   136.97 (+0.18%)
MSFT   256.57 (-0.10%)
META   157.00 (-2.64%)
GOOGL   2,150.08 (-1.34%)
AMZN   107.99 (+1.68%)
TSLA   673.21 (-0.03%)
NVDA   146.24 (-3.53%)
NIO   21.12 (-2.76%)
BABA   115.18 (+1.32%)
AMD   73.61 (-3.74%)
MU   52.58 (-4.88%)
CGC   2.85 (+0.35%)
T   21.05 (+0.43%)
GE   63.03 (-1.01%)
F   11.22 (+0.81%)
DIS   95.10 (+0.74%)
AMC   13.51 (-0.30%)
PFE   51.75 (-1.30%)
PYPL   70.31 (+0.67%)
NFLX   176.67 (+1.03%)
S&P 500   3,774.97 (-0.28%)
DOW   30,695.57 (-0.26%)
QQQ   278.94 (-0.48%)
AAPL   136.97 (+0.18%)
MSFT   256.57 (-0.10%)
META   157.00 (-2.64%)
GOOGL   2,150.08 (-1.34%)
AMZN   107.99 (+1.68%)
TSLA   673.21 (-0.03%)
NVDA   146.24 (-3.53%)
NIO   21.12 (-2.76%)
BABA   115.18 (+1.32%)
AMD   73.61 (-3.74%)
MU   52.58 (-4.88%)
CGC   2.85 (+0.35%)
T   21.05 (+0.43%)
GE   63.03 (-1.01%)
F   11.22 (+0.81%)
DIS   95.10 (+0.74%)
AMC   13.51 (-0.30%)
PFE   51.75 (-1.30%)
PYPL   70.31 (+0.67%)
NFLX   176.67 (+1.03%)
LON:FBT

First Trust NYSE Arca Biotechnology UCITS ETF Share Forecast, Price & News

GBX 1,375.11
+7.61 (+0.56%)
(As of 07/1/2022 02:14 PM ET)
Add
Compare
Today's Range
1,369.53
1,375.30
50-Day Range
1,220.30
1,384.60
52-Week Range
1,220.30
1,560.40
Volume
71 shs
Average Volume
1,602 shs
Market Capitalization
£4.06 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive FBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology UCITS ETF and its competitors with MarketBeat's FREE daily newsletter.

FBT Stock Forecast (MarketRank)

Overall MarketRank

0.88 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
First Trust NYSE Arca Biotechnology UCITS ETF logo

About First Trust NYSE Arca Biotechnology UCITS ETF (LON:FBT)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content. The company operates under the brand name of Blackbird. The company was founded in 1998 and is based in London, the United Kingdom.

FBT Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Software - Application
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£870.31 thousand
Cash Flow
GBX 388 per share
Book Value
GBX 1.90 per share

Miscellaneous

Free Float
N/A
Market Cap
£4.06 billion
Optionable
Optionable
Beta
N/A














First Trust NYSE Arca Biotechnology UCITS ETF Frequently Asked Questions

How has First Trust NYSE Arca Biotechnology UCITS ETF's stock price performed in 2022?

First Trust NYSE Arca Biotechnology UCITS ETF's stock was trading at GBX 1,468.98 at the beginning of the year. Since then, FBT stock has decreased by 6.4% and is now trading at GBX 1,375.11.
View the best growth stocks for 2022 here
.

Who are First Trust NYSE Arca Biotechnology UCITS ETF's key executives?

First Trust NYSE Arca Biotechnology UCITS ETF's management team includes the following people:
  • Mr. Ian McDonough, CEO & Director (Age 47)
  • Mr. Stephen B. Streater, Founder, Director of R&D and Exec. Director
  • Mr. Stephen James White, Chief Operating & Financial Officer and Director (Age 48)
  • Adrian Lambert, Marketing Director
  • Rachel Darcy, Sales Director

What other stocks do shareholders of First Trust NYSE Arca Biotechnology UCITS ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology UCITS ETF investors own include Taylor Wimpey (TW), ARK Genomic Revolution Multi-Sector ETF (ARKG), Johnson & Johnson (JNJ), Weyerhaeuser (WY), AbbVie (ABBV), ARK Innovation ETF (ARKK), Alibaba Group (BABA), Bristol-Myers Squibb (BMY), Global X Robotics & Artificial Intelligence ETF (BOTZ) and Caterpillar (CAT).

What is First Trust NYSE Arca Biotechnology UCITS ETF's stock symbol?

First Trust NYSE Arca Biotechnology UCITS ETF trades on the London Stock Exchange (LON) under the ticker symbol "FBT."

How do I buy shares of First Trust NYSE Arca Biotechnology UCITS ETF?

Shares of FBT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is First Trust NYSE Arca Biotechnology UCITS ETF's stock price today?

One share of FBT stock can currently be purchased for approximately GBX 1,375.11.

How much money does First Trust NYSE Arca Biotechnology UCITS ETF make?

First Trust NYSE Arca Biotechnology UCITS ETF (LON:FBT) has a market capitalization of £4.06 billion and generates £870.31 thousand in revenue each year.

How many employees does First Trust NYSE Arca Biotechnology UCITS ETF have?

First Trust NYSE Arca Biotechnology UCITS ETF employs 20 workers across the globe.

How can I contact First Trust NYSE Arca Biotechnology UCITS ETF?

First Trust NYSE Arca Biotechnology UCITS ETF's mailing address is Tuition House, 27-37 St. Georges Road, LONDON, SW19 4EU, United Kingdom. The official website for First Trust NYSE Arca Biotechnology UCITS ETF is www.forbidden.co.uk. The company can be reached via phone at +44-20-88797245.

This page (LON:FBT) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.